Results
|
|
21.
|
Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation. [electronic resource] by
- Dercksen, M W
- Rodenhuis, S
- Dirkson, M K
- Schaasberg, W P
- Baars, J W
- van der Wall, E
- Slaper-Cortenbach, I C
- Pinedo, H M
- Von dem Borne, A E
- van der Schoot, C E
Producer: 19950911
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 13
Availability: No items available.
|
|
|
22.
|
Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium. [electronic resource] by
- Seferina, Shanly C
- Ramaekers, Bram L T
- de Boer, Maaike
- Dercksen, M Wouter
- van den Berkmortel, Franchette
- van Kampen, Roel J W
- van de Wouw, Agnès J
- Voogd, Adri C
- Tjan Heijnen, Vivianne C G
- Joore, Manuela A
Publication details: Oncotarget Oct 2017
In:
Oncotarget vol. 8
Availability: No items available.
|
|
|
23.
|
Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium. [electronic resource] by
- Seferina, Shanly C
- Lobbezoo, Dorien J A
- de Boer, Maaike
- Dercksen, M Wouter
- van den Berkmortel, Franchette
- van Kampen, Roel J W
- van de Wouw, Agnès J
- de Vries, Bart
- Joore, Manuela A
- Peer, Petronella G M
- Voogd, Adri C
- Tjan-Heijnen, Vivianne C G
Producer: 20160505
In:
The oncologist vol. 20
Availability: No items available.
|
|
|
24.
|
Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium. [electronic resource] by
- van Kampen, R J W
- Ramaekers, B L T
- Lobbezoo, D J A
- de Boer, M
- Dercksen, M W
- van den Berkmortel, F
- Smilde, T J
- van de Wouw, A J
- Peters, F P J
- van Riel, J M G
- Peters, N A J B
- Tjan-Heijnen, V C G
- Joore, M A
Producer: 20170821
In:
European journal of cancer (Oxford, England : 1990) vol. 79
Availability: No items available.
|
|
|
25.
|
Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome. [electronic resource] by
- Lobbezoo, Dorien J A
- van Kampen, Roel J W
- Voogd, Adri C
- Dercksen, M Wouter
- van den Berkmortel, Franchette
- Smilde, Tineke J
- van de Wouw, Agnes J
- Peters, Frank P J
- van Riel, Johanna M G H
- Peters, Natascha A J B
- de Boer, Maaike
- Borm, George F
- Tjan-Heijnen, Vivianne C G
Producer: 20140527
In:
Breast cancer research and treatment vol. 141
Availability: No items available.
|
|
|
26.
|
A real-life study on the implementation and effectiveness of exemestane plus everolimus per hospital type in patients with advanced breast cancer. A study of the Southeast Netherlands Advanced Breast Cancer registry. [electronic resource] by
- Knapen, L M
- Geurts, S M E
- Ibragimova, K I E
- Croes, S
- Vriens, B E P J
- van den Berkmortel, F W P J
- Dercksen, M W
- van de Wouw, A J
- Pepels, M J A E
- de Fallois, A O J
- Lobbezoo, D J A
- de Boer, M
- Tjan-Heijnen, V C G
Producer: 20190624
In:
Breast (Edinburgh, Scotland) vol. 44
Availability: No items available.
|
|
|
27.
|
Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? [electronic resource] by
- Lobbezoo, D J A
- van Kampen, R J W
- Voogd, A C
- Dercksen, M W
- van den Berkmortel, F
- Smilde, T J
- van de Wouw, A J
- Peters, F P J
- van Riel, J M G H
- Peters, N A J B
- de Boer, M
- Peer, P G M
- Tjan-Heijnen, V C G
Producer: 20150709
In:
British journal of cancer vol. 112
Availability: No items available.
|
|
|
28.
|
In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium. [electronic resource] by
- Lobbezoo, D J A
- van Kampen, R J W
- Voogd, A C
- Dercksen, M W
- van den Berkmortel, F
- Smilde, T J
- van de Wouw, A J
- Peters, F P J
- van Riel, J M G H
- Peters, N A J B
- de Boer, M
- Peer, P G M
- Tjan-Heijnen, V C G
Producer: 20161111
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 27
Availability: No items available.
|
|
|
29.
|
Alternating Treatment With Pazopanib and Everolimus vs Continuous Pazopanib to Delay Disease Progression in Patients With Metastatic Clear Cell Renal Cell Cancer: The ROPETAR Randomized Clinical Trial. [electronic resource] by
- Cirkel, Geert A
- Hamberg, Paul
- Sleijfer, Stefan
- Loosveld, Olaf J L
- Dercksen, M Wouter
- Los, Maartje
- Polee, Marco B
- van den Berkmortel, Franchette
- Aarts, Maureen J
- Beerepoot, Laurens V
- Groenewegen, Gerard
- Lolkema, Martijn P
- Tascilar, Metin
- Portielje, Johanna E A
- Peters, Frank P J
- Klümpen, Heinz-Josef
- van der Noort, Vincent
- Haanen, John B A G
- Voest, Emile E
Producer: 20170420
In:
JAMA oncology vol. 3
Availability: No items available.
|
|
|
30.
|
Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis. [electronic resource] by
- Aarts, Maureen J
- Vriens, Birgit E
- de Boer, Maaike
- Peters, Frank P
- Mandigers, Caroline M
- Dercksen, M Wouter
- Stouthard, Jacqueline M
- Tol, Jolien
- van Warmerdam, Laurence J
- van de Wouw, Agnes J
- Jacobs, Esther M
- van der Rijt, Carin C D
- Smilde, Tineke J
- van der Velden, Annette W
- Peer, Nelly
- Tjan-Heijnen, Vivianne C G
Producer: 20180301
In:
Oncology vol. 93
Availability: No items available.
|
|
|
31.
|
The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry. [electronic resource] by
- Pouwels, X G L V
- Geurts, S M E
- Ramaekers, B L T
- Erdkamp, F
- Vriens, B E P J
- Aaldering, K N A
- van de Wouw, A J
- Dercksen, M W
- Smilde, T J
- Peters, N A J B
- Riel, J M van
- Pepels, M J
- Heijnen-Mommers, J
- Joore, M A
- Tjan-Heijnen, V C G
- de Boer, M
Producer: 20200601
In:
Acta oncologica (Stockholm, Sweden) vol. 59
Availability: No items available.
|
|
|
32.
|
Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia. [electronic resource] by
- Aarts, Maureen J
- Peters, Frank P
- Mandigers, Caroline M
- Dercksen, M Wouter
- Stouthard, Jacqueline M
- Nortier, Hans J
- van Laarhoven, Hanneke W
- van Warmerdam, Laurence J
- van de Wouw, Agnes J
- Jacobs, Esther M
- Mattijssen, Vera
- van der Rijt, Carin C
- Smilde, Tineke J
- van der Velden, Annette W
- Temizkan, Mehmet
- Batman, Erdogan
- Muller, Erik W
- van Gastel, Saskia M
- Borm, George F
- Tjan-Heijnen, Vivianne C G
Producer: 20140123
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 31
Availability: No items available.
|
|
|
33.
|
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01). [electronic resource] by
- de Groot, Stefanie
- Pijl, Hanno
- Charehbili, Ayoub
- van de Ven, Saskia
- Smit, Vincent T H B M
- Meershoek-Klein Kranenbarg, Elma
- Heijns, Joan B
- van Warmerdam, Laurence J C
- Kessels, Lonneke W
- Dercksen, M Wouter
- Pepels, Manon J A E
- van Laarhoven, Hanneke W M
- Vriens, Birgit E P J
- Putter, Hein
- Fiocco, Marta
- Liefers, Gerrit-Jan
- van der Hoeven, Jacobus J M
- Nortier, Johan W R
- Kroep, Judith R
Producer: 20200226
In:
Breast cancer research : BCR vol. 21
Availability: No items available.
|
|
|
34.
|
Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01). [electronic resource] by
- Charehbili, A
- van de Ven, S
- Smit, V T H B M
- Meershoek-Klein Kranenbarg, E
- Hamdy, N A T
- Putter, H
- Heijns, J B
- van Warmerdam, L J C
- Kessels, L
- Dercksen, M
- Pepels, M J
- Maartense, E
- van Laarhoven, H W M
- Vriens, B
- Wasser, M N
- van Leeuwen-Stok, A E
- Liefers, G J
- van de Velde, C J H
- Nortier, J W R
- Kroep, J R
Producer: 20141209
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.
|
|
|
35.
|
Cost effectiveness of primary pegfilgrastim prophylaxis in patients with breast cancer at risk of febrile neutropenia. [electronic resource] by
- Aarts, Maureen J
- Grutters, Janneke P
- Peters, Frank P
- Mandigers, Caroline M
- Dercksen, M Wouter
- Stouthard, Jacqueline M
- Nortier, Hans J
- van Laarhoven, Hanneke W
- van Warmerdam, Laurence J
- van de Wouw, Agnes J
- Jacobs, Esther M
- Mattijssen, Vera
- van der Rijt, Carin C
- Smilde, Tineke J
- van der Velden, Annette W
- Temizkan, Mehmet
- Batman, Erdogan
- Muller, Erik W
- van Gastel, Saskia M
- Joore, Manuela A
- Borm, George F
- Tjan-Heijnen, Vivianne C
Producer: 20140123
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 31
Availability: No items available.
|
|
|
36.
|
Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience. [electronic resource] by
- Vriens, Ingeborg J H
- Ter Welle-Butalid, Elena M
- de Boer, Maaike
- de Die-Smulders, Christine E M
- Derhaag, Josien G
- Geurts, Sandra M E
- van Hellemond, Irene E G
- Luiten, Ernest J T
- Dercksen, M Wouter
- Lemaire, Bea M D
- van Haaren, Els R M
- Vriens, Birgit E P J
- van de Wouw, Agnes J
- van Riel, Anne-Marie M G H
- Janssen-Engelen, Sandra L E
- van de Poel, Marlène H W
- Schepers-van der Sterren, Ester E M
- van Golde, Ron J T
- Tjan-Heijnen, Vivianne C G
Producer: 20210108
In:
Breast cancer research and treatment vol. 181
Availability: No items available.
|